Recently it was demonstrated that the excessive expression of iNOS is able to decrease the expression level of CXCL12 gene, which has been implicated in the restriction of immune cell invasion to the CNS and the neuroinflammation limit in animal model of MS (Petković et al., 2013). This evidence concerns the gene NOS2 and myeloid sarcoma.